Allergy Therapeutics
AGY.L
#7054
Rank
NZ$0.75 B
Marketcap
$0.16
Share price
1.45%
Change (1 day)
223.58%
Change (1 year)

EPS for Allergy Therapeutics (AGY.L)

EPS in 2023: -$0.17

According to Allergy Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.17. In 2023 the company made an earnings per share (EPS) of -$0.17 a decrease over its 2022 EPS that were of -$0.04516.

EPS history for Allergy Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023-$0.17269.76%
2022-$0.04516-516.78%
2021$0.01084-54.41%
2020$0.0237795.71%
2019$0.01215-141.62%
2018-$0.02918206.98%
2017-$0.009506-82.28%
2016-$0.05364-9900.7%
2015$0.0005473-88.46%
2014$0.00474137.81%
2013$0.003440-49.58%
2012$0.006823-128.37%
2011-$0.02405-562.56%
2010$0.005199-101.26%
2009-$0.41-52.19%
2008-$0.86-13.07%
2007-$0.99230.64%
2006-$0.30182.5%
2005-$0.11-211.47%
2004$0.09499-59.61%
2003$0.24-219.2%
2002-$0.20